Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLIT3 | CTRPv2 | pan-cancer | AAC | -0.24 | 9e-10 |
mRNA | CEP295NL | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-08 |
mRNA | TIMP2 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-07 |
mRNA | AGRN | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
mRNA | ZBTB4 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
mRNA | CTSA | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |
mRNA | LAMA5 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
mRNA | CD151 | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-06 |
mRNA | FAM114A1 | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-06 |
mRNA | GRAMD3 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-07 |